Results 211 to 220 of about 280,160 (254)

People living with HIV display increased anti-apolipoprotein A1 auto-antibodies, inflammation, and kynurenine metabolites: a case-control study. [PDF]

open access: yesFront Cardiovasc Med
Frias MA   +10 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

High-Density Lipoproteins and Apolipoprotein A1.

Sub-cellular biochemistry, 2020
High-density lipoprotein (HDL) and its main protein component apolipoprotein (apo)A-I, play an important role in cholesterol homeostasis. It has been demonstrated that HDLs comprise of a very heterogeneous group of particles, not only regarding size but also composition.
Emiel P. C. van der Vorst
semanticscholar   +3 more sources

Probiotic kefir consumption improves serum apolipoprotein A1 levels in metabolic syndrome patients: a randomized controlled clinical trial.

Nutrition Research, 2022
Metabolic syndrome has become a major health hazard of the modern world. Studies investigating the effects of traditional fermented foods on metabolic syndrome are limited. We hypothesized that regular kefir consumption could improve the anthropometrical
E. Bellikci-Koyu   +5 more
semanticscholar   +1 more source

Bisphenol A disturbs hepatic apolipoprotein A1 expression and cholesterol metabolism in rare minnow Gobiocypris rarus.

Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, 2021
Bisphenol A (BPA) is a well-known plasticizer, which is widely distributed in the aquatic environment. Lots of studies showed that BPA could lead to lipid metabolism disorder in fish, but few studies studied the mechanism from the perspective of lipid ...
Zhu Zhu   +5 more
semanticscholar   +1 more source

Apolipoprotein A1 and B

Clinics in Laboratory Medicine, 2006
This article reviews the evidence showing that apolipoprotein (apo) B and A-1 are superior to the conventional cholesterol indices as analytes in laboratory practice, indices of the lipoprotein-related risk for vascular disease, and measures of the adequacy of low-density lipoprotein-lowering therapy.
Allan D, Sniderman, Santica M, Marcovina
openaire   +2 more sources

Plasma apolipoprotein A1 and birthweight

The Lancet, 1997
Vol 350 • December 20/27, 1997 1823 delivered, 2·0 Gy daily until 30 Gy, without any benefit. 9 months after the diagnosis, a left pleural chylous effusion developed (figure). Thoracocentes had to be done every 2 weeks. The patient lost weight and his general strength decreased.
J F, Morlese, F, Jahoor, T E, Forrester
openaire   +2 more sources

Extensive Intimal Apolipoprotein A1-Derived Amyloid Deposits in a Patient with an Apolipoprotein A1 Mutation

Biochemical and Biophysical Research Communications, 1998
In the aortic intima amyloid deposits are often associated with atherosclerotic plaques. In a recent study of one patient with aortic intimal amyloid the major fibril protein was an N-terminal fragment of apolipoprotein A1 (apoA1) consisting of 69 amino acid residues.
M, Amarzguioui   +6 more
openaire   +2 more sources

Clinical Value of Serum Amyloid-A Protein, High-density Lipoprotein Cholesterol and Apolipoprotein-A1 in the Diagnosis and Follow-up of Neonatal Sepsis

The Pediatric Infectious Disease Journal, 2020
Supplemental Digital Content is available in the text. Background: To evaluate the performance of serum amyloid-A (SAA), high-density lipoprotein cholesterol (HDL-C) and apolipoprotein-A1 (Apo-A1) levels in the identification and monitoring of neonatal ...
Vasiliki Bourika   +5 more
semanticscholar   +1 more source

Determination of non-enzymatically glycated apolipoprotein A1

Clinical Biochemistry, 1989
A procedure for the quantitation of non-enzymatically glycated apolipoprotein A1 (GApoA1) was developed and optimized. Glycated total protein was separated from plasma using m-aminophenyl-boronate affinity chromatography. Apolipoprotein A1 present in the glycated and non-glycated fractions of each sample was determined by rate nephelometry, and the ...
P S, Caines   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy